http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007106681-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_370ca28a580f6b11f2ed9bd04a153e55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2005-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_834e1a6203d0ca0690843ff09b4b76d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7164da92e049289d13cf7c90900649 |
| publicationDate | 2007-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007106681-A |
| titleOfInvention | Vaccine immunotherapy |
| abstract | The present invention provides a vaccine and a vaccine administration method that can induce a strong antigen-specific immune response without showing side effects such as an autoimmune phenomenon. A vaccine characterized by being administered a certain time after administration of an adjuvant. [Selection figure] None |
| priorityDate | 2005-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.